tion and allergy arc modulated by oxygenated metabolites of arachidonic acid ( A A ; 20:4, 1 1 -6 or 20:4, ( I J -~) and related polyunsaturated fatty acids that are collectivcly termed cicosanoids. These compounds include prostaglandins (PGs), prostacyclin (PGI), thromboxane (TXA), leukotricncs and hydroxylated derivatives (epoxides) of A A .
Precursors of cellular eicosanoids are essential fatty acids which must be provided in the diet. Synthesis o f eicosanoids is under the control o f specific cellular enzymes mediating the uptake, release and oxygenation o f the precursor fatty acid.
Mammalian cell membranes consist of a lipid bilayer composed primarily of phospholipids and cholesterol. Proteins that have important cellular signalling functions such as receptors. transporters and enzymes are embedded in the lipid bilayer. Although the following review will focus
o n the modification of the cicosanoid system and other mediator compounds by dietary fatty acids, it is clear that some of the resulting changes in cell signalling might be more directly related to the modifications in the fatty acid composition of membrane phospholipids and their effects o n those proteins embedded in the lipid bilayer. The following review describes briefly some o f the important factors involved in the pathogenesis o f atherosclerosis and chronic inflammation/cell proliferation and how t i -3 fatty acids interfere at several sites with this process.
Eicnstrrioicls trritl c~l l .sigriirlliri~
As shown in Fig. I . eicosanoids and related lipid mediators. such as l .2-diacylglyccrol (DAG) or platelet-activating factor (PAF ), exert a modulatory role in coupling cellular responses t o various stimuli and in mediating cell-cell interactions. Thus, some eicosanoids like thromboxane A?, leukotriene B, (LTB,) and cytochrome 1'-450 products of AA may amplify an initial (Ca' +-related) signal for cell activation by stimulating specific membrane receptors coupled t o phospholipase C. thereby further increasing intracellular Ca' + concentrations. In contrast, other eicosanoids, such as PGI, or PGD, may blunt an initial signal for cell activation by decreasing intracellular Ca? + release via an increase in cyclic AMP (for details see I I I).
Nirtritiori t i r i d the eieosrrrioicl sy.steni
Interference with eicosanoid synthesis is characteristic of anti-inflammatory drugs and antithrombotic agents. antihypertensives and diuretics, suggesting that eicosanoids are involved in a broad spectrum of prevailing diseases. A change in eicosanoid production and eicosanoid-dependent cellular functions may. however. also be achieved by altering eicosanoid precursor availability. Under our 'western' dietary conditions. AA acid is by far the dominant precursor fatty acid o f biologically highly active cicosanoids o f the two series (Fig. 2 ). The major primary source o f AA in our food chain is linoleic acid (LA; I X:2. t i -6). At variance t o the fatty acids of the linoleic or I I -6 family in terrestrial animals and in most plant seeds. which are the major sources of our cicosanoid precursor fatty acids. the fatty acids of the ( Ilinoleic or t i -3 family predominate in green leaves and especially in marine lipids. Here, eicosapentaenoic acid (EPA: 20: 5. ti -3) and docosahexaenoic acid (DHA:
2 2 : 6 , t i -3) are the major polyunsaturnted fatty acids. The desaturation step from the t i -h fatty acids to the t i -3 fatty acids seems t o be carried out exclusively in green leaves and phytoplankton t o form (r-LA ( I8 : 3. 11 -3) from linoleic acid
( 1 X : 2 . r 1 -6 ) .
In the mammalian organism fatty acids belonging to diffcrent families such a s t i -3 and t i -6 fatty acids cannot be interconverted. Therefore. nutritional intake determines the fatty acid composition o f phospholipids in plasma and in cell membranes to ii great extent. In this respect 'we are what we eat'[ 1, 141.
Several independent lines of evidence; epidemiological, experimental and biochemical. suggest that changes in the natural history of hypertensive, atherothrombotic and inflammatory disorders may be achieved by altering the eicosanoid precursor availability.
In Table I . approximate numbers of the frequency o f coronary heart disease (CHI)) in three populations anti the characteristic differences in the content of A A and EPA (C20: 5. t i -3) in membrane phospholipids. illustrate this intriguing relationship. In fact, with the idoption of western dietary habits, leading t o an increase in fat intake and a relative reduction o f ti -3 fatty acid content in their diet. the Japanese have experienced increasing mortality rates from CHDII].
Riochemicul efects of' t i -.?fiitty iicic1.s
In the following is a brief description of t i -3 fatty acids o n factors and mechanisms involved in the pathophysiology of atherosclerosis and inflammation (summarized in Table 2 ). The transformations depicted by the arrows incorporate two or more reaction steps. The arching arrow indicates that only in leaves and algae is 11-6 LA desaturated to form ti -3 a-LA. the progenitor of the t i -3 class of fatty acids. AA. In the mammalian organism, LA (C 18 : 2, I I -61, the i i i~~, animal and human studies show that platelets are more parent fatty acid of the I I -6 fatty acid family. is slowly sticky and lead t o thrombus formation. Recently, a new role dcsaturated and elongated t o AA (C20:4, I I -6). the of A A and some of its metabolites in thc intracellular signaldominant precursor fatty acid o f eicosanoids under our ling pathway associated with cell proliferation and gene western dietary conditions. A A is a potent aggregator of expression has been suggested 131. Such a function would platelets in v i m 121. After infusion or dietary intake of A A in place A A into a strategic position t o modulate key cellular VOl. 18 events in atherosclerotic and chronic inflammatory disorders.
ti -3 fatty acids do not only replace AA and LA in certnin cellular phospholipids (especially phosphatidylcholine and phosphatidylcthanolamine) but they redistribute these I I -6 fatty acids from the phospholipid fraction into cholesterol esters and triacylglyccrols [ 4-6 I. Together with the high affinity of t i -3 fatty acids to the ether lipid fraction of phospholipids. this may have important implications for the composition of spccific intracellular lipid pools and the formation of lipid mediators from AA or EPA.
M A . Owing t o the early findings o n fish oils and platelet aggregation. and the potential role of EPA ( C 2 0 : 5 . I I -3) as an cicosanoid precursor, the effects of fish oil o n eicosanoids were the first t o be studied 17). At least two prostanoids, TXA and PGI are involved in atherogenesis. TXA, produced in platelets from AA. is o f the 2-series (TXA,) and promotes platelet aggregation. an important early stage in blood-clot formation and in atherogenesis. It also is a potent constrictor of arteries. I I -3 fatty acids inhibit the formation of TXA, and lead to the formation of small quantities o f inactive l'rost[icycliti. PGI, produced by endothelial cells, exerts opposite actions t o TXAs. It prevents platelets from aggregating and dilates arteries: its actions are antiathcrogenic. Whereas TXA formed from EPA. unlike that from AA. has very littlc physiological activity. prostacyclin (PGI,) formed from EPA [91 and DHA after retroconversion t o EPA [ 101 is fully active, increasing the total anti-atherogenic (PGI) activity. Thus, the presence of EPA from fish oil in the phospholipds of membranes of platelets and cndothelial cells, and in plasma, tips the balance in the blood vessels away from atherosclerosis 11 11.
Lcirkotricvirs. Leukotriencs are potent prointlamniatory and immunoactivc factors. LTB,, produced from AA, is a chemoattractant for neutrophils and monocytes/ macrophages. These circulating white blood cells arc important elements in inflammation and are major cellular constituents of early atherosclerotic lesions. LTB, also leads to the activation of neutrophils and macrophages. LTB, produced from EPA, on the other hand, has little physiological effect, so that on replacement of A A by EPA in cell membrane phospholipids, the inflammatory component of atherosclerosis is diminished [ 12, 13 I.
Disturbances o f the ccll signalling process are thought to play a major role in diseases like atherosclerosis and chronic inflammation. Arachidonic acid and its metabolites formed via the cyclo-oxygenase, lipoxygenase o r the cytochrome 1'-450 pathways, may be important modulators of this process. The mechanisms involved include also the formation o r release o f messenger molecules such as inositol phosphates [e.g. insositol trisphosphate (IP,)], Ca'+ and DAG. II -3 fatty acids have been found t o interfere at several sites in this signalling process [ 141.
I'lutelet-uctivating fuctor. PAF is a phospholipid-like molecule now known t o possess many widespread and largely adverse physiological effects. At least some of these; the activation of platelets (as its name indicates) and of monocytes/macrophages, contribute to atherogenesis and inflammation. PAF can be synthesizd by several different cell types. It has been shown in humans, that the production of PAF is markedly inhibited when the 11-3 fatty acids are incorporated in their membrane phospholipids replacing A A as the precursor molecules for PAF formation [ 151.
I'lutelet-derived growth fuctor (PDGF ). Once platelets aggregate, as they will at a site of injury to the endothelial cells, they release several factors including a potent chemoattractant and mitogen, responsible, in part, for the migration of smooth muscle cells from deeper layers of the arterial wall t o the site of endothelial injury of dysfunction where they TXA, 1x1.
multiply. PDGF, along with other factors. causes circulating monocytes. another type of white blood cells. t o migrate also t o the site of endothelial injury. t o niultiply t o ;I changc into macrophages which are scavenger cells in the developing atherosclerotic process.
Not only platelets, but also the other cell types that participate in the development o f atherosclerosis. i.e. endothelial cells. monocytes/macrophagcs. and smooth muscle cells, produce PDGF-like proteins which stimulate cell growth in the aterial wall. When the low-dcnsity lipoprotein (LIIL) cholesterol level in the blood is elevated and oxidized after trapping in the vascular intima. it is the macrophi1ges and smooth muscle cells that ingest thc cholesterol t o form foam cells which contribute t o the atherosclerotic plaqucs. Recently. it has been shown that incorporating E'PA into cultured aortic endothelial cells markedly reduces their production of PDGF-like proteins I 161.
Oxvgeti free rciclicds. An important means by which neutrophils and monocytes fight infection is t o attack invading bacteria or foreign cells with lethal oxygen free radicals. These highly reactive oxygen species, however. can damage normal cells and. in fact. arc thought to be responsible for the cellular debris component o f the atherosclerotic plaque. It has been demonstrated that fceding fish oils results in a large reduction in oxygen free radical formation by neurophils and monocytcs when these cells are activated 1 I7 I. Furthermore, the formation o f lipid hydroperoxides in plasma is reduced after dietary fish oil [ I 81.
Iriterleirkiw I utid tiirirortr tiecmsis firctor. lnterleukin I (IL-1 ). a peptide molecule produced by several o f the cell types discussed here that are incriminated in the dcvelopment of atherosclerosis, has been shown t o cause most o f the physiological effects associated with infections: fever. malaise, sleepiness. etc. In concert with another peptide. tumour necrosis factor (TNF). it is also responsible for several effects that are atherogenic: it stimulates synthesis o f adhesion molecules (proteins which cause monocytes t o adhere t o endothelial cells). stimulates production of cytotoxic oxygen frcc radicals by neutrophils and monocytcs and activates platelets, neutrophils and monocytes. Again, it has been shown that fceding fish oil supplements t o humans reduces the production o f both IL-l and TNF I 191.
These actions o f fish oils may be protective not only against athcroscleosis. but they may have bcncficial effects o n modulating the cxcessivc o r misdirected activity o f the immune system as well, which is thought t o be responsible for the so-called autoimmune diseases like lupus 120l. rheumatoid arthritis 12 11 o r colitis [ 221. So far, thcrc has been no report suggesting that such damping down of the immunc system by fish oils creates an increased risk o f infections o r cancer.
Etidot/wIiid cell-d~v-ii itvl rdii.vutioti j i i t w l : E ndc ) t hclial ccl Iderived relaxing factor (EDRF). a s its name implies. promotes relaxation o f arterial smooth muscle cells and diminishes constriction o f arteries when exposed t o several physiological and pharmacological vasoconstrictor agents. These actions of EDRF are enhanced by supplementing diets of experimental animals with fish oils 1231. In addition, it has been found that these potentially anti-athcrosclcrotic actions persist even after exposure o f arteries t o moxic conditions, as may occur with decreased blood flow during and following a heart attack 124).
~b l l c~l l~. s i o l l
At present we do not know the biological significance and the cause of the fact that A A constitutes by far the major precursor fatty acid o f eicosanoids and related lipid mediators under our westcrn dietary conditions. One reason might be the increasingly uniform supply o f saturated and t i -6 unsaturated fatty acids in our food chain. i.e. in vegetnhlc oils and in livestock fattened with grain rich in CIX:?. I I -6. which is slowly desaturated and elongated t o AA i n the mammalian organism. T h e further evaluation of the relationship between ti -6 vcsus ti -3 fatty acids and their cicosanoids and membrane receptor function, the modulation o f transmembrane signalling mechanisms, phospholipasc activation. formation of I .2-DAG and PAF, 
